文献
J-GLOBAL ID:202202257509603315
整理番号:22A0472765
リキリチゲニンはARHGAP18の促進とRhoA/ROCK1経路の抑制を介してドキソルビシン誘発慢性心不全を軽減する【JST・京大機械翻訳】
Liquiritigenin alleviates doxorubicin-induced chronic heart failure via promoting ARHGAP18 and suppressing RhoA/ROCK1 pathway
著者 (9件):
Xu Zhibing
(Department of Emergency, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, China)
,
Hu Zongde
(Department of Traditional Chinese Medicine, Shanghai Pudong New Area Hospital of Traditional Chinese Medicine, China)
,
Xu Hanchen
(Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, China)
,
Zhang Lifen
(Department of Emergency, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, China)
,
Li Liang
(Department of Emergency, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, China)
,
Wang Yi
(Department of Emergency, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, China)
,
Zhu Yuanqing
(Department of Emergency, Seventh People’s Hospital of Shanghai University of Traditional Chinese Medicine, China)
,
Yang Limeng
(Department of Traditional Chinese Medicine, Shanghai Pudong New Area Hospital of Traditional Chinese Medicine, China)
,
Hu Dan
(Department of Traditional Chinese Medicine, Shanghai Pudong New Area Hospital of Traditional Chinese Medicine, China)
資料名:
Experimental Cell Research
(Experimental Cell Research)
巻:
411
号:
2
ページ:
Null
発行年:
2022年
JST資料番号:
B0313A
ISSN:
0014-4827
CODEN:
ECREAL
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)